Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42.9M
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
37.6M
-
Shares change
-
+2.53M
-
Total reported value, excl. options
-
$3.45B
-
Value change
-
+$245M
-
Put/Call ratio
-
1.4
-
Number of buys
-
115
-
Number of sells
-
-67
-
Price
-
$91.86
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q2 2014
222 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q2 2014.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.6M shares
of 42.9M outstanding shares and own 87.51% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (4.73M shares), GILDER GAGNON HOWE & CO LLC (3.27M shares), FMR LLC (3.11M shares), JENNISON ASSOCIATES LLC (2.53M shares), VANGUARD GROUP INC (2.08M shares), BlackRock Fund Advisors (1.35M shares), DARUMA CAPITAL MANAGEMENT LLC (1.13M shares), MARSICO CAPITAL MANAGEMENT LLC (1.08M shares), BlackRock Institutional Trust Company, N.A. (978K shares), and NEXT CENTURY GROWTH INVESTORS LLC (968K shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.